Cell culture metabolomics in the diagnosis of lung cancer - The influence of cell culture conditions

Journal of Breath Research

Volumn 8, Issue 2, 2014, Pages

  Kalluri, U ^a   Naiker, M ^a   Myers, M A ^a  

^a UNIVERSITY OF BALLARAT   (Australia)

Author keywords

cancer; cell culture; hypoxia; metabolomics; volatile organic compounds (VOCs)

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; PYRUVATE DEHYDROGENASE KINASE; PYRUVATE DEHYDROGENASE KINASE 1; TUMOR MARKER; UNCLASSIFIED DRUG; VOLATILE ORGANIC COMPOUND; BIOLOGICAL MARKER;

ARTICLE; BREATH ANALYSIS; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PATIENT; CANCER SCREENING; CAPILLARY GAS CHROMATOGRAPHY; CELL METABOLISM; CELL PROTECTION; DIAGNOSTIC TEST; EARLY DIAGNOSIS; EXPIRED AIR; GLUCOSE INTAKE; HUMAN; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; ION MOBILITY SPECTROMETRY; LIPID METABOLISM; LIPID PEROXIDATION; LUNG CANCER; LUNG CANCER CELL LINE; METABOLOMICS; NON INVASIVE PROCEDURE; OXIDATION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; CELL HYPOXIA; CULTURE TECHNIQUE; LUNG TUMOR; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; REVIEW;

BIOLOGICAL MARKERS; BREATH TESTS; CELL CULTURE TECHNIQUES; CELL HYPOXIA; HUMANS; LUNG NEOPLASMS; METABOLOMICS; VOLATILE ORGANIC COMPOUNDS;

EID: 84901628702     PISSN: 17527155     EISSN: 17527163     Source Type: Journal    
DOI: 10.1088/1752-7155/8/2/027109     Document Type: Article

References (73)

1. Ginsberg R J, Vokes E E and Rosenzweig K 2012 Cancer: Principles and Practice of Oncology vol 1 6th edn ed V T De Vita, S Hellman and S A Rosenberg (Baltimore, MD: Williams and Wilkins) p 667
2. Mathers C D and Loncar D 2006 Projections of global mortality and burden of disease from 2002 to 2030 PLOS Med. 3 e442
3. Jemal A, Center M M, DeSantis C and Ward E M 2010 Global patterns of cancer incidence and mortality rates and trends Cancer Epidemiol. Biomar. 19 1893-907
4. Phillips M, Cataneo R N, Cummin A R, Gagliardi A J, Gleeson K, Greenberg J, Maxfield R A and Rom W N 2003 Detection of lung cancer with volatile markers in the breath Chest 123 2115-23 (Pubitemid 36706741)
5. Folkman J, Hahnfeldt P and Hlatky L 2000 Cancer: looking outside the genome Nature Rev. Mol. Cell Bio. 1 76-79
6. Vaupel P 2004 Tumor microenvironmental physiology and its implications for radiation oncology Semin. Radiat. Oncol. 14 198-206 (Pubitemid 38903223)
7. Hakim M, Broza Y Y, Barash O, Peled N, Phillips M, Amann A and Haick H 2012 Volatile organic compounds of lung cancer and possible biochemical pathways Chem. Rev. 112 5949-66
8. Tisch U, Billan S, Ilouze M, Phillips M, Peled N and Haick H 2012 Volatile organic compounds in exhaled breath as biomarkers for the early detection and screening of lung cancer CML Lung Cancer 5 107-17
9. Miekisch W, Schubert J K and Noeldge-Schomburg G F 2004 Diagnostic potential of breath analysis-focus on volatile organic compounds Clin. Chim. Acta 347 25
10. Philips M 1992 Breath tests in medicine Sci. Am. 267 74-79
11. Amann A 2012 Breath analysis for clinical diagnosis and therapeutic monitoring Siriraj Med. J. 64 18-19
12. Risby T H and Solga S F 2006 Current status of clinical breath analysis Appl. Phys. B 85 421-6 (Pubitemid 44451363)
13. Mitsubayashia K, Matsunagab H, Nishiob G, Todab S and Nakanishib Y 2005 Bioelectronic sniffers for ethanol and acetaldehyde in breath air after drinking Biosensors Bioelectron. 20 1573-9
14. Ochiaia N, Takinoa M, Daishimab S and Cardinc B D 2001 Analysis of volatile sulphur compounds in breath by gas chromatography-mass spectrometry using a three-stage cryogenic trapping preconcentration system J. Chromatogr. B 762 67-75
15. Pauling L, Robinson B A, Teranishi R and Cary P 1971 Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography Proc. Natl Acad. Sci. USA 68 2374-6
16. Phillips M, Herrera J, Krishnan S, Zain M, Greenberg J and Cataneo R N 1999 Variation in volatile organic compounds in the breath of normal humans J. Chromatogr. B 729 75-88 (Pubitemid 29264111)
17. Dallinga W J, Robroeks C M H T T, Van Berkel J J B N, Moonen E J C, Godshalk R W L, Jöbsis Q, Dompeling E, Wouters E F M and Van Schooten F J 2010 Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children Clin. Exp. Allergy 40 68-76
18. Van Berkel B N J J, Dallinga W J, Möller M G, Godschalk W L R, Moonen J E, Wouters F M E and Van Schooten J F 2010 A profile of volatile organic compounds in breath discriminates COPD patients from controls Respir. Med. 104 557-63
19. Hauschild C A, Baumbach I J and Baumbach J 2012 Integrated statistical learning of metabolic ion mobility spectrometry profiles for pulmonary disease identification Genet. Mol. Res. 11 2733-44
20. 2 - an integrated medical software system for early lung cancer detection using ion mobility spectrometry data of human breath J. Integr. Bioinform. 4 75
21. Khalid Y T et al 2013 Breath volatile analysis from patients diagnosed with harmful drinking, cirrhosis and hepatic encephalopathy: a pilot study Metabolomics 9 938-48
22. Risby T H 2008 Critical issues for breath analysis J. Breath Res. 2 030302
23. Miekisch W and Schubert J 2006 From highly sophisticated analytical techniques to life-saving diagnostics: technical developments in breath analysis Trend Anal. Chem. 25 665-73 (Pubitemid 44093743)
24. Kneepkens C M, Lepage G and Roy C C 1992 The hydrocarbon breath test in the study of lipid peroxidation: principles and practice Clin. Invest. Med. 15 163-86
25. Kneepkens C M, Lepage G and Roy C C 1994 The potential of the hydrocarbon breath test as a measure of lipid peroxidation Free Radic. Biol. Med. 17 127-60 (Pubitemid 24217183)
26. Ray G, Batra S, Shukla N K, Deo S, Raina V, Ashok S and Hussain S A 2000 Lipid peroxidation, free radical production and antioxidant status in breast cancer Breast Cancer Res. Treat. 59 163-70 (Pubitemid 30216139)
27. Loft S and Poulsen H E 1996 Cancer risk and oxidative DNA damage in man J. Mol. Med. 74 297-312 (Pubitemid 26195901)
28. Hietanen E, Bartsch H, Bereziat J C, Camus A M, Mc Clinton S, Eremin O, Davidson L and Boyle P 1994 Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study Eur. J. Clin. Nutr. 48 575-86 (Pubitemid 24245230)
29. Norberg Å, Jones W A, Hahn G R and Gabrielsson L J 2003 Role of variability in explaining ethanol pharmacokinetics Clin. Pharmacokinet. 42 1-31
30. Turner C, Španěl P and Smith D 2006 A longitudinal study of ethanol and acetaldehyde in the exhaled breath of healthy volunteers using selected-ion flow-tube mass spectrometry Rapid Commun. Mass Spectrom. 20 61-68 (Pubitemid 41815180)
31. Risby T H 2005 Trace gas analysis in exhaled human breath for disease diagnosis CLEO: Conf. on Lasers and Electro-Optics vol 2 pp 898-9 (Pubitemid 43110509)
32. Ledochowski M, Widner B, Murr C, Sperner-Unterweger B and Fuchs D 2001 Fructose malabsorption is associated with decreased plasma tryptophan Scand. J. Gastroenterol. 36 367-71 (Pubitemid 32250731)
33. Stone B G, Besse T J, Duane W C, Evans C D and DeMaster E G 1993 Effect of regulating cholesterol biosynthesis on breath isoprene excretion in men Lipids 28 705-8 (Pubitemid 23241435)
34. Phillips M, Cataneo N R, Joel G, Gunawardena R and Naidu A 2000 Effect of age on the breath methylated alkane contour, a display of apparent new markers of oxidative stress J. Lab. Clin. Med. 136 243-9
35. Remmer H, Hintze T, Frank H and Müh-zange M 1984 Cytochrome P-450 oxidation of alkanes originating as scission products during lipid peroxidation Xenobiotica 14 207-19 (Pubitemid 14161676)
36. Anderson M L, Beebe E L, Fox D S, Issaq J H and Kovatch M R 1991 Promotion of mouse lung tumors by bioaccumulated polychlorinated aromatic hydrocarbons Exp. Lung Res. 17 455-71
37. Benhamou S and Bonaïti-Pellié C 1995 Susceptibility to bronchial cancer: an example of genetic-environmental interaction Ann. Biol. Clin. 53 507-13 (Pubitemid 26037661)
38. Hecht S S 1997 Approaches to cancer prevention based on an understanding of N-nitrosamine carcinogenesis Exp. Biol. Med. 216 181-91
39. Minro W 1998 Polymorphic CYP genes and disease predisposition-What have the studies shown so far? Toxicol. Lett. 167 2-3
40. Zevin S and Benowitz N L 1999 Drug interactions with tobacco smoking: an update Clin. Pharmacokinet. 36 425-38 (Pubitemid 29317490)
41. Buszewski B, Kesy M, Ligor T and Amann A 2007 Human exhaled air analytics: biomarkers of diseases Biomed. Chromatogr. 21 553-66 (Pubitemid 46937852)
42. Zolotov A Y 2005 Breath analysis J Anal Chem. 60 497
43. Jordan A, Hansel A, Holzinger R and Lindinger W 1995 Acetonitrile and benzene in the breath of smokers and non-smokers investigated by proton transfer reaction mass spectrometry (PTR-MS) Int. J. Mass Spectrom. 148 L1-3
44. Kushch I et al 2008 Compounds enhanced in a mass spectrometric profile of smokers' exhaled breath versus non-smokers as determined in a pilot study using PTR-MS J. Breath Res. 2 026002
45. Nagrath D, Caneba C, Karedath T and Bellance N 2011 Metabolomics for mitochondrial and cancer studies Biochim. Biophys. Acta 1807 650-63
46. Kim Y S, Maruvada P and Milner J A 2008 Metabolomics in biomarker discovery: future uses for cancer prevention Future Oncol. 4 93-102 (Pubitemid 351372610)
47. Nicholson J K, Lindon J C and Holmes E 1999 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 29 1181-9
48. Nicholson J K, Connelly J, Lindon J C and Holmes E 2002 Metabonomics: a platform for studying drug toxicity and gene function Nature Rev. Drug Discov. 1 153-62
49. Sponring A, Filipiak W, Mikony T, Ager C, Schubert J, Miekisch W, Amann A and Troppmair J 2009 Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro Anticancer Res. 29 419-26
50. Chen X, Xu F, Wang Y, Pan Y, Lu D, Wang P and Zhang W 2007 A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis Cancer 110 835-44 (Pubitemid 47257662)
51. Filipiak W, Sponring A, Filipiak A, Ager C, Schubert J, Miekisch W and Tropmair J 2010 TD-GC-MS analysis of volatile metabolites of human lung cancer and normal cells in vitro Cancer Epidemiol. Biomarkers 19 182-95
52. Smith D, Wang T, Sulé-Suso J, Španěl P and Haj A E 2003 Quantification of acetaldehyde released by lung cancer cells in vitro using selected ion flow tube mass spectrometry Rapid Commun. Mass Spectrom. 17 845-50 (Pubitemid 36433170)
53. Filipiak W, Sponring A, Mikoviny T, Ager C, Schubert J, Miekisch W, Amann A and Tropmair J 2008 Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro Cancer Cell Int. 8 17
54. Poli D, Carbognani P, Corradi M, Goldoni M, Acampa O, Balbi B and Mutti A 2005 Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study Respir. Res. 6 71
55. Yu J, Wang D, Wang L, Wang P, Hu Y and Ying K 2009 Detection of lung cancer with volatile organic biomarkers in exhaled breath and lung cancer cells AIP Conf. Proc. 198 1137
56. Yu H, Xu L and Wang P 2005 Solid phase microextraction for analysis of alkanes and aromatic hydrocarbons in human breath J. Chromatogr. B 826 69-74 (Pubitemid 41446436)
57. Wehinger A, Schmid A, Mechtcheriakov S, Ledochowski M, Grabmer C, Gastl G A and Amman A 2007 Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas Int. J. Mass Spectrom. 265 49-59
58. Fuchs P, Loeseken C, Schubert J K and Miekisch W 2010 Breath gas aldehydes as biomarkers of lung cancer Int. J. Cancer 126 2663-70
59. Sponring A, Filipiak W, Ager C, Schubert J, Miekisch W, Amann A and Troppmair J 2010 Analysis of volatile organic compounds (VOCs) in the headspace of NCI-H1666 lung cancer cells Cancer Biomark. 7 153-61
60. Deng C, Zhang X and Li N 2004 Investigation of volatile biomarkers in lung cancer blood using solid-phase microextraction and capillary gas chromatography-mass spectrometry J. Chromatogr. B 808 269
61. Gordon M S, Szidon J, Krotoszynski B K, Gibbons R D and O'Neill H J 1985 Volatile organic compounds in exhaled air from patients with lung cancer Clin. Chem. 31 1278-82 (Pubitemid 16041914)
62. Vaupel P, Mayer A and Höckel M 2004 Tumor hypoxia and malignant progression Method Enzymol. 381 335-54 (Pubitemid 38401518)
63. Harris A L 2002 Hypoxia-a key regulatory factor in tumour growth Nature Rev. Cancer 2 38-47 (Pubitemid 37328806)
64. Semenza G L 2003 Targeting HIF-1 for cancer therapy Nature Rev. Cancer 3 721-32 (Pubitemid 37328811)
65. Simiantonaki N, Jayasinghe C, Michel-Schmidt R, Peters K, Hermanns I M and Kirkpatrick J C 2008 Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines Int. J. Oncol. 32 585-92 (Pubitemid 351330464)
66. Jain R K 2002 Tumor angiogenesis and accessibility: role of vascular endothelial growth factor Semin. Oncol. 29 3-9
67. Wilson G D 2007 Hypoxia and prognosis: the oxygen tension mounts Front. Biosci. 12 3502-18
68. Wenger R H 2002 Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression FASEB J 16 1151-62 (Pubitemid 34815403)
69. Papandreou I, Cairns R A, Fontana L, Lim A L and Denko N C 2006 HIF-1mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption Cell Metab. 3 187-97
70. Kim W J, Tchernyshyov I, Semenza L G and Dang V C 2006 HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia Cell Metab. 3 177-85
71. Brahimi-Horn M C and Pouyssegur J 2007 Oxygen, a source of life and stress FEBS Lett 581 3582-91 (Pubitemid 47081011)
72. Vaupel P, Kallinowski F and Okunieff P 1989 Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review Cancer Res. 49 6449-65 (Pubitemid 20008770)
73. Frezza C, Zheng L, Tennant D A, Papkovsky D B, Hedley B A, Kalna G, Watson G D and Gottlieb E 2011 Metabolic profiling of hypoxic cells revealed a catabolic signature required for cell survival PLOS One 6 e24411